PulseLife buys Invivox to build a European clinical decision and training platform

What's the deal? France's PulseLife, part of the 360 Medical groupDealroom has a profile for this one. Try Dealroom →, has acquired Invivox, a leading platform for continuing medical education and healthcare professional engagement. The deal was announced in September 2026; terms were not disclosed.

What do they do? PulseLife runs an AI-powered clinical decision support system, while Invivox operates a continuing training platform for care providers. Together, they aim to serve clinicians across their full practice: reliable, sourced information at the point of decision, plus ongoing skills development through training.

What's the endgame? The 360 Medical group says the combination creates an integrated European player linking clinical decision-making and professional training, so that each feeds the other. It describes the result as a "continuum d'accompagnement unique en Europe" (translated from French: a unique continuum of support in Europe).

The signal: The deal reflects a wider push in European medtech to bundle clinical tools and education into single platforms, betting that combining decision support with training deepens adoption among healthcare professionals.

Read more: lyonbiopole.com

Image credit: EU-Ukraine cooperation